Exploring how platelet count relates to bleeding scores in ITP patients
Assessment of Bleeding Scores in Immune Thrombocytopenia Purpuria
This study looks at how platelet counts affect bleeding symptoms in adults with immune thrombocytopenia purpura (ITP) to help improve treatment and management of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT06273956 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the relationship between platelet count and bleeding scores in patients diagnosed with immune thrombocytopenia purpura (ITP). It aims to compare the clinical practicability of various bleeding grading systems in adult ITP patients, recognizing that bleeding symptoms can vary widely among individuals. The study will retrospectively analyze data to understand how platelet levels correlate with bleeding severity, which is crucial for managing this condition effectively.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with primary immune thrombocytopenia.
Not a fit: Patients with malignancies, viral infections, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management of bleeding risks in ITP patients by providing better assessment tools.
How similar studies have performed: Other studies have explored bleeding assessment tools in ITP, indicating a foundation for this research, though the specific relationship being examined may be novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of primary ITP . Exclusion Criteria: * Malignancy disease * Virus infection: * HIV * Hepatitis B virus * Hepatitis C virus * Pregnancy.
Where this trial is running
Assiut
- Aml Sayed Hamed — Assiut, Egypt (Recruiting)
Study contacts
- Study coordinator: Rania Mohammed Mahmoud Hafez, professor
- Email: raniahafez@aun.edu.eg
- Phone: +201000019198
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.